CONFÉRENCIER:
Professeur Mark Hogarth
Burnet Principal for Research Strategy
Head; Inflammation, Cancer and Infection
Burnet Institute, Melbourne, Australia
Titre: FcR:IgG interaction in humans and non-human primates: Implications for next generation therapeutic monoclonal antibodies
Invité par Dr Andrés Finzi